4575.T
CanBas Co.,Ltd.
グロース · 医薬品 · 医薬品 · JP
JPY 766.00
+0.39%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- —
- EBIT
- +7.6%
- EPS
- +10.1%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- -61.4%
Three-year CAGR
- Revenue
- —
- EBITDA
- —
- EBIT
- +12.1%
- Net income
- +4.3%
- EPS
- +10.0%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026